Multiple Sclerosis Therapeutics Market Size 2020 With Regional Scope, Report Coverage, Historic Data, Outlook 2027
Multiple Sclerosis Therapeutics Market 2020 Global Industry Market research report provides key analysis on the market status of the Multiple Sclerosis Therapeutics manufacturers with market size, growth, share, trends as well as industry cost structure. Granular market information gathered in this Multiple Sclerosis Therapeutics report will be helpful to Multiple Sclerosis Therapeutics industry to take competent business decisions. This global market research report is a window for the complete overview of the market where it covers various aspects such as product definition, segmentation based on various parameters, and the prevailing vendor landscape. The research study carried out in Multiple Sclerosis Therapeutics report also helps to recognize the various drivers and restraints impacting the market during the forecast period. By applying consistent knowledge throughout the report, research, analysis and estimations are drawn in this Multiple Sclerosis Therapeutics market report.
Get a sample of PDF:- https://www.theinsightpartners.com/sample/TIPRE00004057/?utm_source=theprose&utm_medium=10209
Global Multiple Sclerosis Therapeutics Market: Regional Analysis
The report offers in-depth assessment of the growth and other aspects of the Multiple Sclerosis Therapeutics market in important regions. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.
The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2020 to 2027. These analyses will help the reader to understand the potential worth of investment in a particular region.
Global Multiple Sclerosis Therapeutics Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, during the forecast period of 2020 to 2027.
Major Key Points of Multiple Sclerosis Therapeutics Market
· Multiple Sclerosis Therapeutics Market Overview
· Multiple Sclerosis Therapeutics Market Competition
· Multiple Sclerosis Therapeutics Market, Revenue and Price Trend
· Multiple Sclerosis Therapeutics Market Analysis by Application
· Company Profiles and Key Figures in Multiple Sclerosis Therapeutics Market
· Market Dynamics
· Methodology and Data Source
Leading market players and manufacturers are studied to help give a brief idea about them in the report. The challenges faced by them and the reasons they are on that position is explained to help make a well informed decision. Competitive landscape of Brown Sugar market is given presenting detailed insights into the company profiles, developments, merges, acquisitions, economic status and best SWOT analysis.
NOTE: Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 analysis of markets and industries. Cordially get in touch for more details.
TABLE OF CONTENTS
Introduction
Key Takeaways
Research Methodology
Multiple Sclerosis Therapeutics Market Landscape
Multiple Sclerosis Therapeutics Market - Key Market Dynamics
Multiple Sclerosis Therapeutics Market - Global Market Analysis
Multiple Sclerosis Therapeutics Market - Revenue and Forecasts To 2027 - Segmentation
Overview
Multiple Sclerosis Therapeutics Market Revenue and Forecasts To 2027 - Geographical Analysis
Industry Landscape
Multiple Sclerosis Therapeutics Market, Key Company Profiles
Appendix
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Malaria Treatment Market Trends, Business Growth and Major Driving Factors 2028
Malaria Treatment Market, Malaria Treatment Market 2028, Malaria Treatment Industry, Malaria Treatment Sector, Malaria Treatment PDF Report, Malaria Treatment Analysis, Malaria Treatment Forecast, Malaria Treatment Research, Competitive Analysis
The malaria treatment market was valued at US$ 1,638.27 million in 2021; registering at a CAGR of 4.9% from 2022 to 2028, according to a new research study conducted by The Insight Partners.
Oral Segment to Lead Malaria Treatment Market During 2022–2028
The report highlights the key factors driving the market and prominent players with their developments. The market growth is primarily attributed to an increasing prevalence of malaria and the government and private sector's initiatives to raise awareness about malaria. However, counterfeit antimalarial drugs and subsequent drug resistance are hindering the market growth.
According to the World Health Organization (WHO), malaria is an acute febrile illness caused by plasmodium parasites, which spread through the bites of infected female Anopheles mosquitoes. Malaria is caused by five parasite species in humans, and two of these species—Plasmodium falciparum and P. vivax pose the greatest threat. P. falciparum is the deadliest malarial parasite, and it is the most widespread one on the African continent. P. vivax is the dominant malarial parasite in most countries outside of sub-Saharan Africa. According to the World malaria report (WMR) 2020 by the WHO, 241 million cases of malaria were reported in 2020, compared to 227 million cases recorded in 2019. The number of deaths caused due to malaria reached 0.62 million in 2020, with an annual rise of 69,000 deaths. While approximately two-thirds of these deaths (47,000) were due to disruptions in healthcare services during the COVID-19 pandemic, the remaining one-third of deaths (22,000) reflected a recent change in WHO’s methodology for calculating malaria mortality (irrespective of COVID-19 disruptions). As per the WHO, Africa continues to account for a disproportionately high share of the global burden of malaria. In 2020, 95% of the global cases of malaria and 96% of deaths were reported in Africa; ~80% of the total deaths caused by malaria are reported in children below 5 years of age. Four African countries Nigeria (31.9%), the Democratic Republic of the Congo (13.2%), the United Republic of Tanzania (4.1%), and Mozambique (3.8%) accounted for nearly half of all malaria-related deaths reported worldwide. According to the LANCET Regional Health 2020, the burden of malaria is the highest in African countries (95%); P. falciparum is the cause of the brunt of mortality in children younger than 5 (∼77%) across the world, and in African countries, this species accounts for ∼96% of total mortalities caused among children by malaria. Furthermore, P. vivax has been a causal agent of 2% (4.5 million) of the total cases, mostly from Asia. According to WMR 2021, ∼2% of the global burden of malaria is borne by Southeast Asian countries, and India contributed 83% of estimated malaria cases and 82% of malaria deaths in Southeast Asia in 2020. Hence, the rising prevalence of malaria in different regions of the world boosts the malaria treatment market growth.
Moreover, counterfeit antimalarial drugs and subsequent drug resistance hinder the overall malaria treatment market growth. The resistance spreading among plasmodium species against existing antimalarial drugs is a growing concern. The World malaria report 2021 by the WHO has highlighted the emergence of partial resistance to artemisinin in Africa. The occurrence of antimalarial drug resistance can be due to the growing appearance and use of counterfeit drugs, overuse of certain medications for prevention, incomplete treatment of active infections, and the parasite's adaptability at the genetic and metabolic levels, among others. The elevated prevalence of counterfeit antimalarial drugs is a major concern faced by healthcare sectors worldwide. These drugs are dominant in most African countries; since medical costs are high in these countries, people may opt for counterfeits for receiving treatments at lower costs, while some countries lack reasonable quality control and verification processes. According to the Journal of Vector Borne Diseases 2020, counterfeit antimalarial drugs not only result in an economic loss but also decrease the efficacy of treatment resulting in the loss of faith in the health system and increasing the chances of drug resistance in the parasites. Counterfeit drugs also hamper the intellectual property-based innovation paradigms. The presence of counterfeit antimalarial drugs significantly leads to a rise in the number of deaths in developing countries. Thus, the surging dominance of counterfeit antimalarial drugs and the subsequent rise in drug resistance among plasmodium species are hindering the malaria treatment market growth.
Based on route of administration, the malaria treatment market is segmented into oral, parenteral & intravenous. The oral segment held the largest share of the market in 2021, and it is also expected to grow rapidly during the forecast period. Oral drug delivery is the most preferred and suitable route of drug administration in malaria patients as it offers high patient compliance, noninvasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form, and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are major factors fueling the adoption of oral drugs. The low manufacturing cost of tablets, capsules, and other orally administered drugs acts as a driving factor for the malaria treatment market growth. A few of the available anti-malarial drugs are quinine, quinidine, chloroquine, amodiaquine, tafenoquine proguanil, chlorproguanil, and artemisinin. ACTs and the combination therapies are being used for the treatment of uncomplicated malaria caused by P. falciparum parasite. ACTs are the most effective antimalarial medicines in the market, acting as a standalone factor responsible for the market growth in the oral segment.
Zydus Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Cipla Ltd, Viatris Inc, Lupin Ltd, AdvaCare Pharma USA LLC, and VLP Therapeutics LLC are among the leading companies operating in the malaria treatment market.
The report segments the malaria treatment market as follows:
Based on treatment, the malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. Based on drug type, the malaria treatment market is bifurcated into branded and generic. Based on route of administration, the malaria treatment market is bifurcated into oral and parenteral & intravenous. Based on distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. Based on end user, the malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. By geography, the malaria treatment market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, Nigeria, Democratic Republic of Congo, United Republic of Tanzania, Mozambique, Uganda, Ghana, Burkina Faso, Kenya, Zambia, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Reason to Buy
· Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Malaria Treatment Market.
· Highlights key business priorities in order to guide the companies to reform their business strategies and establish themselves in the wide geography.
· The key findings and recommendations highlight crucial progressive industry trends in the Malaria Treatment Market, thereby allowing players to develop effective long-term strategies in order to garner their market revenue.
· Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
· Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those restraining the growth at a certain extent.
Order a copy of this research Malaria Treatment Market research report at –
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Pharmaceutical Excipients Market Size, Share, Analysis Report by Types, Applications and Forecast 2028
The rising number of product approvals and launches drives the pharmaceutical excipients market growth. Formulation scientists have recognized that single-component excipients do not always provide the requisite performance to allow certain APIs to be manufactured adequately. These scientists focus on the production of co-processed and multifunctional excipients with enhanced performance. Co-processed excipients are a mixture of two or more existing excipients at the sub-particle level, offering substantial benefits of the incorporated excipients and minimizing their drawbacks. These multipurpose excipients have dramatically reduced the number of incorporating excipients in the tablet. The co-processed excipients are used to improve the drug's flow, disintegration, lubrication, and compressibility. The excipients also simplify the formulation process and make it cost-effective. They are increasingly used to convert complicated and labor-intensive formulation processes, such as wet granulation, to quick direct-compression processes, without affecting the final product quality or performance. Co-processed excipients play a crucial role in the creation of a stable, result-oriented drug delivery system with enhanced chemical, physical, and mechanical properties.
Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00003534/
Excipients are an integral component of pharmaceutical products that determine the structure of dosage type and its role in delivering drugs. Excipients significantly affect the process ability, aesthetics, efficiency, and patient compliance with the dosage form. Thus, the use of excipients in a formulation requires an assurance and a clear understanding of their quality, safety, and performance attributes. The principal role of excipients is to support patient acceptability, enhance stability, bioavailability, and assist in the effectiveness.
Thus, the rise in the sale of generic drugs across the world propels the demand for pharmaceutical excipients used in manufacturing generic drugs.
Based on type, the pharmaceutical excipients market is segmented into bioresorbable polymers, lipids, and liposome-based formulation; oleochemicals; sugars; cellulose; starches; petrochemicals; plant proteins, polyols and cyclodextrins; inorganic chemicals; and others. The inorganic chemicals segment is expected to account for the largest share of the market in 2022. However, the plant proteins, polyols and cyclodextrins segment is anticipated to register the highest CAGR in the market during the forecast period.
JRS PHARMA GmbH & Co KG, Roquette Freres SA, BASF SE, Evonik Industries AG, AshLand Inc, Archer-Daniels-Midland Co, The Dow Chemical Co, The Lubrizol Corp, Avantor Inc, and MEGGLE GmbH & Co KG., Univar Solutions Inc. are a few of the key companies operating in the pharmaceutical excipients market.
The report segments the pharmaceutical excipients market as follows:
The pharmaceutical excipients market is segmented based on type, clinical indication, functionality, application, end user, and geography. Based on type, the market is segmented into bioresorbable polymers, lipids, and liposome-based formulation; oleochemicals; sugars; cellulose; starches; petrochemicals; plant proteins, polyols and cyclodextrins; inorganic chemicals; and others. Based on clinical indication, the market is segmented into cancer, metabolic, infectious diseases, dental, ophthalmic, gene therapies, and others.
Based on functionality, the market is segmented into coloring agent & coating agent; sweetener & flavoring agents; suspending & viscosity agents; preservative & controlled-release; antioxidant & oil; tablet filler & diluents; binders, compression aids and granulating agents; and others. Based on application, the market is segmented into parenteral, oral formulations & tablets, capsules, liquid & injectables, physicochemical excipient-container interactions in prefilled syringes, nutraceuticals & OTC, topical, and others. Based on end user, the market is segmented into biopharma industries, pharma industries, animal health, and others.
By geography, the pharmaceutical excipients market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of SAM).
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
Contact US
Contact Person : Sameer Joshi .
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com
Brain Health Supplements Market Size, Growth, Industry Trends, Global Demand, and Forecast 2023-2028
The global brain health supplements market is expected to reach at US$ 14,249.53 million by 2028. registring at a CAGR of 11.7% from 2022 to 2028, according to a new research study conducted by The Insight Partners.
Natural Molecules Segment to Lead Brain Health Supplements Market During 2022–2028
According to our latest study on "Brain Health Supplements Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, Dosage Form, Distribution Channel, and Age Category," the market is expected to grow from US$ 6,634.3 million in 2021 to US$ 14,249.5 million by 2028; it is estimated to grow at a CAGR of 11.7% from 2022 to 2028.
The report highlights the key factors driving the market and prominent players with their developments. The growing prevalence of major depressive disorders and increasing demand for brain supplements among the elderly population primarily boost the market growth. However, the lack of regulations and false claims by manufacturers hinder the growth of the brain health supplements market.
Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00007430/
Depression, which is a common mental disorder, is different from normal mood fluctuations and temporary emotional responses to challenges faced every day. When depression is recurrent with moderate or severe intensity, it may become a severe health issue. It can hamper the performance of affected individuals in homes, workplaces, schools, etc. People suffering from depression are also likely to attempt suicide. According to estimates by the World Health Organization (WHO), 5% of adults (~280 million) suffer from depression globally. Further, according to the National Institute of Mental Health (NIMH), in the US, ~14.8 million adults aged 18 and above (i.e., 6.0% of the total adult population) had at least one major depressive episode with serious impairment in 2020.
Cases of chronic depression are increasing in Europe. According to Eurostat, in 2019, 7.2% of European Union (EU) citizens had chronic depression. In European Union (EU), 12.2% of people in Portugal reported having chronic depression in 2019, followed by Sweden (11.7%), and Germany and Croatia (11.6% both). Per the data published by KPMG International, the prevalence of depression is higher in Asia Pacific compared to the rest of the world, especially in the younger population. According to the National Center for Biotechnology Information (NCBI), there is growing evidence about the role of nutrients in mental health. The adequate consumption of nutrients contributes to better overall health and mental health. Hence, the optimum supply of nutrients as adjunctive therapy to antidepressants is essential for adequate brain functioning. Thus, the growing prevalence of major depressive disorders is driving the growth of the brain health supplements market.
Based on product, the brain health supplements market is segmented into natural molecules, herbal extracts, and vitamins & minerals. The natural molecules segment held the largest share of the market in 2021, and it is also expected to record rapid growth during the forecast period. According to a report by the Uniformed Services University, brain health supplements are mostly natural or herbal nootropics (smart drugs and cognitive enhancers, similar to adaptogens) that include ingredients such as ashwagandha, Bacopa monnieri, Ginkgo biloba, ginseng, huperzine A, omega-3 fatty acids, rhodiola, and valerian. Natural molecules are increasingly being used as supplements as no or negligible side effects are associated with them. Further, nootropic supplement ingredients such as higenamine, sulbutiamine, and hordenine are approved by the US Food and Drug Administration (FDA) under the "Dietary Supplement Ingredient Advisory List" based on the preliminary evaluation for the ingredients not appearing to be lawfully included and sold under dietary supplement products.
Health Via Modern Nutrition Inc. (HVMN Inc.); Unilever PLC; Quincy Bioscience; Peak Nootropics; Danone SA; Harbin Pharmaceutical Group Co.; Purelife bioscience Co., Ltd; Procera Health; Natural Factors; and LIQUID HEALTH, INC. are among the leading companies operating in the brain health supplements market.
The report segments the brain health supplements market as follows:
Based on product, the brain health supplements market is segmented into natural molecules, herbal extracts, and vitamins & minerals. In terms of application, the market is segmented into memory enhancement, attention & focus, depression & mood, sleep & recovery, antiaging & longevity, and others. The brain health supplements market, by dosage form, is segmented into tablets, capsules, and others. Based on distribution channel, the brain health supplements market is segmented into supermarket & hypermarket, drug store, online, and others. In terms of age category, the market is segmented into adults, children, and elderly. By geography, the brain health supplements market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
Contact US
Contact Person : Sameer Joshi .
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com
Pharmaceutical Fluid Handling Market Size, Growth, Industry Trends, Global Demand, and Forecast 2023-2028
The pharmaceutical fluid handling market is projected to reach US$ 14,209.40 million by 2028; registering at a CAGR of 4.7% from 2022 to 2028, according to a new research study conducted by The Insight Partners.
Equipment Segment Dominated Pharmaceutical Fluid Handling Market in 2021
Increasing drug production and growing adoption of single-use systems in the pharmaceutical industry are the factors that contribute to the pharmaceutical fluid handling market growth. However, high price of failed clinical trials restricts the market growth.
Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00029767/
Increase in Vaccine Production Provides Opportunity to Pharmaceutical Fluid Handling Market
Vaccines strengthen the immune system of different age groups, providing protection against infectious diseases. In the past few decades, effective immunization has eliminated polio and smallpox, which registered high mortality rates. In recent years, there has been an increase in vaccination demand due to the rising incidences of viral and bacterial infectious diseases. Further, government foundations, hospitals, and pharmaceutical companies are focusing on regular vaccine administration by providing cost-effective immunization globally. This is boosting the demand for vaccine production, which is likely to promote the growth of the pharmaceutical fluid handling market. For instance, the Indian Universal Immunization Programme (UPI) rolled out its pneumococcal conjugate vaccine to 21 lakh children. Additionally, government funding and company investments are stimulating R&D to launch new products. According to World Health Organization, in November 2022, a total of 16 billion vaccine doses, valued at US$ 141 billion, were supplied in 2021, which is approximately three times more than the doses supplied in 2019, i.e., 5.8 billion. The Serum Institute of India (SII) postponed HPV vaccine production for two years due to the focus on the development of COVID-19 vaccines; however, it will begin supplying HPV vaccine to the Government of India by 2023 in small quantities. Thus, an increase in vaccine production is anticipated to create an opportunity for the pharmaceutical fluid handling market during the forecast period.
Based on offering, the global pharmaceutical fluid handling market is segmented into equipment and solutions and services. In 2021, the equipment segment held the largest share of the market, and it is expected to register the highest CAGR during 2022–2028. The equipment & solutions segment is further segmented into metering pumps and capsule equipment (filling/sorting), mixing equipment and valves, thermal processing equipment (coolers/chillers/dryers/heat-exchangers), x-ray inspection systems, tanks for holding liquids and flow control products, filters/filter sets (pre-filters/ sterilizing grade filters/ virus filters), powder handling bags, sterile connectors/disconnectors and membrane filter cartridges, and others. Based on tubing, the market is segmented into TPE, PVC, and silicone.
CIRCOR International Inc, Parker Hannifin Corp, Danaher Corp, Spirax Sarco Engineering plc, Merck KGaA, Rochling SE & Co KG, RAUMEDIC AG, Tef Cap Industries Inc, Fraser Ross Ltd, and Australian Fluid Handling Pty Ltd are the key companies operating in the pharmaceutical fluid handling market.
The report segments the pharmaceutical fluid handling market as follows:
The pharmaceutical fluid handling market is segmented on the basis of offering, tubing, application, usage, end user, and geography. Based on offering, the market is segmented into equipment & solutions and services. Based on tubing, the market is segmented into TPE, PVC, and silicone. Based on application, the market is segmented into fluid handling and management, fluid preparation, integration and automation, aseptic processing, buffer management, and others. Based on usage, the market is segmented into cough syrup, intravenous products, complex APIs, and others. Based on end user, the market is segmented into biotechnology companies, pharmaceutical and medical companies, and others.
In terms of geography, the pharmaceutical fluid handling market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
Contact US
Contact Person : Sameer Joshi .
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com
Aquaculture Vaccines Market Trends, Business Growth and Major Driving Factors 2028
According to our new research study on “Aquaculture Vaccines Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type of Vaccine, Species, and Route of Administration,” the market is expected to grow from US$ 245.13 million in 2021 to US$ 569.72 million by 2028; it is estimated to grow at a CAGR of 12.9% from 2022 to 2028.
Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00005403/
The report highlights trends prevailing in the market and factors driving its growth. The market growth is mainly attributed to the growing aquaculture industry and surging demand for aquatic animal-derived food products. However, strict regulatory policies for the approval of vaccines and the high cost of vaccines hamper the market growth.
Based on type of vaccine, the aquaculture vaccines market is segmented into live vaccines, inactivated vaccines, and other vaccines. The inactivated vaccines segment held the largest share of the market in 2021. However, the live vaccines segment is anticipated to register the highest CAGR in the market during the forecast period. The inactivated vaccine is prepared by physical or chemical treatment of the pathogen so that the organisms become inactive (loses replication capability) but maintain their immunogenicity. The vaccine is usually prepared with a virulent strain and is immunogenic. A few examples of chemical inactivating agents are formaldehyde, glutaraldehyde, and beta propiolactone; they change the structural conformation or cross-link the structures and ultimately inactivate the organisms. Advantages of such vaccines are no possibility of reversion, no shedding and contamination of an environment, and stability, thus less need for a cold chain.
The COVID-19 pandemic hampered the manufacturing, healthcare, aerospace & defense, and construction industries in 2020. The pandemic has had adverse impacts on aquaculture value chains. The crisis has negatively affected the aquaculture input supply, thus affecting the aquaculture vaccine market. Inadequate and irregular input supply raised concerns about aquaculture practices, which may undermine future production. In North America, the aquaculture sector was jeopardized by the COVID-19 crisis due to disruptions in input supply and output distribution. The pandemic severely disrupted the marketing of aquaculture products. Globally, the crisis has also affected the livelihoods of millions of people working in the aquaculture sector. Moreover, reduced employment and lower incomes during the pandemic have affected seafood consumption across the world.
Impacts of COVID-19 on fisheries and aquaculture affected supply and demand. Transport and border restrictions reduced the supply. The pandemic and sluggish overseas markets impacted India’s seafood sector as well. The country exported 11,49,341 metric ton of marine products (worth US$ 5.96 billion) during FY 2020–2021, a decrease of 10.8% as compared to seafood export of 12,89,651 metric ton during 2019–2020.
Various measures were taken to mitigate the impact of the pandemic, which would also enable the post-pandemic recovery of the aquaculture sector and the aquaculture vaccine market.
AquaTactics Fish Health, HIPRA SA, Merck & Co Inc, Microsynbiotix Ltd, Indian Immunologicals Ltd, Nisseiken Co Ltd, Zoetis Inc, VETERQUIMICA SA, Phibro Animal Health Corp, Elanco Animal Health Inc., Tecnovax SA are among the leading companies operating in the aquaculture vaccines market.
The report segments the global aquaculture vaccines market as follows:
The aquaculture vaccines market is segmented on the basis of type of vaccine, species, route of administration, and geography. Based on type of vaccine, the market is segmented into live vaccines, inactivated vaccines, and other vaccines. Based on species, the market is segmented into tilapia, trout, salmon, shrimps, and others. By route of administration, the aquaculture vaccines market is segmented into injection vaccines, immersions vaccines, and oral vaccines. Based on geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, Norway, Egypt, and the Rest of Europe), APAC (China, India, Japan, Australia, South Korea, Indonesia, New Zealand, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, Chile, and the Rest of SCAM).
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
Contact US
Contact Person : Sameer Joshi .
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com
Pulmonary Arterial Hypertension Market Trends, Business Growth and Major Driving Factors 2028
The pulmonary arterial hypertension market is expected to grow from US$ 7,369.89 million in 2021 to US$ 10,889.08 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2022 to 2028.
The pulmonary arterial hypertension market is segmented on the basis of drug, type, route of administration, distribution channel, and geography. The report offers insights and in-depth analysis of the pulmonary arterial hypertension market, emphasizing various parameters such as dynamics, trends, and opportunities of the market and competitive landscape analysis of leading market players across various regions. It also includes the impact analysis of COVID–19 pandemic on pulmonary arterial hypertension market across the regions.
Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00005221/
Rising Approvals of Pulmonary Arterial Hypertension Drugs Drives Market Growth
· In September 2022, Toray Industries, Inc. received approval from China’s National Medical Products Administration (NMPA) for Careload tablets to treat pulmonary arterial hypertension (PAH). Careload is an orally administered sustained-release formulation of beraprost sodium, a prostacyclin derivative (PGI2).
· In May 2022, United Therapeutic Corporation received US Food and Drug Administration (FDA) approval for Tyvaso DPI (treprostinil) inhalation powder to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) and pulmonary arterial hypertension (PAH; WHO Group 1) to enhance exercise ability.
· In November 2021, the US FDA granted tentative approval for Yutrepia (treprostinil) inhalation powder. Yutrepia is indicated to treat PAH to improve exercise ability in adult patients with New York Heart Association (NYHA) Functional Class II-III symptoms.
· In July 2021, The Janssen Pharmaceutical Companies of Johnson & Johnson received FDA approval for UPTRAVI (selexipag) injection for intravenous (IV) to treat PAH; WHO Group I in adult patients with WHO functional class (FC) II–III, who are temporarily unable to take oral therapy.
· In August 2021, Aerami Therapeutics, Inc. announced that the FDA granted the company orphan drug designation for imatinib to treat PAH patients. AER– 901, a drug-device combination product candidate for inhaled imatinib for the treatment of PAH, is in a Phase 1 trial with completion targeted for the end of 2021.
Drug-Based Insights
Based on drug, the pulmonary arterial hypertension market is segmented into endothelin receptor antagonists (ERAs), prostacyclin and prostacyclin analogs, sGC stimulators, and pde-5 dipsticks. The prostacyclin and prostacyclin analogs segment held the largest market share in 2021 and is anticipated to register the highest CAGR during 2022–2028. Prostacyclin is a small lipid eicosanoid molecule, also known as prostaglandin, I-2 (PGI-2), produced by endothelial cells and acts locally, inhibiting platelet activation and causing vasodilation. Prostacyclin dilates blood vessels, improves blood flow by preventing the proliferation of vascular smooth muscle cells, and prevents blood clotting by inhibiting platelet aggregation. Prostacyclin analogs have been developed as therapies for PAH. PAH prostacyclin analogs are synthetic forms of prostacyclin, a natural substance produced in the body. Patients affected by PAH tend to have reduced prostacyclin levels, leading to blood vessel constriction and hypertension. PAH prostacyclin analogs supplement the requirement and mimic the action of natural prostacyclin to reduce pulmonary hypertension and reduce associated symptoms.
Route of Administration-Based Insights
Based on route of administration, the pulmonary arterial hypertension market is segmented into oral, intravenous/subcutaneous, and inhalational. The oral segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period. Orally administered agents used for the treatment of symptomatic, moderate-to-severe PAH include sildenafil and the endothelin (ET) receptor antagonists (ERAs), bosentan and sitaxentan (sitaxsentan), and abrisentan oral ET(A) receptor-selective ERA, with higher ET receptor affinity than bosentan. Moreover, new oral drugs for treating PAH include macitentan, riociguat, and treprostinil. Ambrisentan is an endothelin receptor antagonist indicated for treating PAH; WHO Group 1 and delay clinical worsening. In combination with tadalafil, ambrisentan is indicated to reduce the risks of disease progression and hospitalization for worsening PAH, and to improve exercise ability.
Distribution Channel-Based Insights
Based on distribution channel, the pulmonary arterial hypertension market is segmented into hospital pharmacies and clinics, online pharmacies, and retail pharmacies. The hospital pharmacies and clinics segment held the largest market share in 2021 and is anticipated to register the highest CAGR during the forecast period. Hospital pharmacy strives to continuously maintain and improve patients' medication management and pharmaceutical care to the highest standards in a hospital setting. Pharmacists in this field are responsible for dispensing medications, quality testing, formulating and re-formulating dosage forms, monitoring, reporting drug safety, and preparing budgets for medications.
About US
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.
Contact US
Contact Person : Sameer Joshi .
Phone : +1-646-491-9876
E-mail : sales@theinsightpartners.com
Sutherlandia Extract Market Size, Growth, Industry Trends, Global Demand, and Forecast 2023-2028
The Sutherlandia Extract Market is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Sutherlandia Extract Market with detailed market segmentation by type, applications, end-user, and geography. The report provides key statistics on the market status of the leading Sutherlandia Extract Market players and offers key trends and opportunities in the market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Sutherlandia Extract Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, and the key development in the past five years.
Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00029343/
Top Key Players:- Afriplex, Medico Herbs, Global Fusion Naturals, Afrinatural, Geva SA, The sutherlandia Company, Afrigetics CC, Body and Mind, TMG Health, Qualfon and Others
It is an African legume that has traditionally been used as a native medicine for a variety of ailments. It aids the body in rooting out or cleaning out viruses that may be present and can improve the functioning of lymph nodes, thymus glands, and other parts of the body. Sutherlandia extract has the ability to reverse the destructive process of viruses in the body, allowing the poisons to be unraveled and corrected. Sutherlandia extract also has anti-diabetic properties, because it normalizes insulin levels and glucose uptake in peripheral tissues while suppressing intestinal glucose uptake.
Drivers:
The growing awareness about Sutherlandia extract in the pharmaceutical industry is anticipated to propel the growth of the market during the forecast period.
The rising prevalence of chronic diseases such as cancer and diabetes across the globe is expected to spur market growth in the coming years.
Increasing usage of Sutherlandia extracts in dietary supplements and other nutritional products
Restraints:
Side effects of sutherlandia extract such as slight dizziness, diarrhea, and dry mouth, among others can impede the market growth.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South And Central America after evaluating political, economic, social and technological factors affecting the Sutherlandia Extract Market in these regions.
Table of Contents
· Report Overview: It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study.
· Executive Summary: It covers industry trends with high focus on market use cases and top market trends, market size by regions, and global market size. It also covers market share and growth rate by regions.
· Key Players: Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players.
· Breakdown by Product and Application: This section provides details about market size by product and application.
· Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast.
· Profiles of International Players: Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details.
· Market Dynamics: It includes supply chain analysis, analysis of regional marketing, challenges,
Continued....
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
Contact Us:
The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Cancer Vaccines Market Share, Analysis Report Trends by Types, Applications and Forecast 2027
According to our new market research study on "Cancer Vaccines Market to 2027 – Global Analysis and Forecast by Technology, Type, Indication, and End User," the market is expected to reach US$ 15,845.59 million by 2027 from US$ 4,568.82 million in 2019; it is estimated to grow at a CAGR of 17.2% from 2020 to 2027. The report highlights trends prevailing in the global cancer vaccines market, and the drivers and restraints pertaining to the market growth.
Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://bit.ly/40iZbpi
Based on technology, the cancer vaccines market is segmented into dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, and viral vector cancer vaccines. In 2019, the recombinant cancer vaccines segment accounted for the largest share of the market, and it is further estimated to register the highest CAGR during the forecast period. Growth of the market for this segment is attributed to the escalating demand for effective vaccines and rising prevalence of cancer. In addition, strategic activities by service providers such as collaborations, mergers, acquisitions, and expansions are further accelerating the growth of the market.
The global cancer vaccines market growth is mainly attributed to factors such as increasing incidence of cancer worldwide, and rising number of initiatives taken by healthcare research organizations and key cancer vaccines companies. However, a limited number of commercially available vaccines for treatment of cancer and higher cost of cancer vaccines hinder the market growth.
CSL Limited, ADURO BIOTECH INC., Astellas Pharma Inc., Merck & Co., Inc., Sanofi, Bristol-Myers Squibb Company, Glaxosmithkline Plc., Dendreon, ASTRAZENECA PLC., and OSE Immunotherapeutics are among the leading companies operating in the cancer vaccines market.
Cancer is among the leading cause of deaths across the globe and is profoundly affecting the quality of life. Thus, cancer would be a burden on society if not diagnosed and treated on time. According to the World Health Organization (WHO), in 2018, approximately 9.6 million deaths reported across the globe were due to cancer. Furthermore, the National Cancer Institute predicted that in 2018, approximately 1,735,350 new cancer cases would be diagnosed in the US. Approximately, 1.9 million new cancer cases and 693,000 cancer deaths were recorded in 2018, in North America. Prostate cancers are the most commonly diagnosed cancers among males in North America; however, breast cancer remains the leading cancer in females. As per the estimations by the American Cancer Society, breast cancer is the most common type of cancer in the US as it caused morbidity in ~234,087 people and lead to 41,904 deaths in 2018. Further, ~276,480 new cases are expected in the country in 2020. As per the Globocan 2019 report, in Germany, the total number of breast cancer cases in 2018 was 71,888, and the disease lead to ~19,376 deaths in that year. Additionally, lung cancer remains the most common cause of death in both sexes. It is estimated that the number of new cases of cancer incidence is 439.2 per 100,000 men and women per year. According to the National Health Profile, the cases of common cancers, including cervical, oral, and breast cancers have increased by 324% in India between 2017 and 2018.
Table of Contents
· Report Overview: It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study.
· Executive Summary: It covers industry trends with high focus on market use cases and top market trends, market size by regions, and global market size. It also covers market share and growth rate by regions.
· Key Players: Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players.
· Breakdown by Product and Application: This section provides details about market size by product and application.
· Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast.
· Profiles of International Players: Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details.
· Market Dynamics: It includes supply chain analysis, analysis of regional marketing, challenges,
Continued....
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
Contact Us:
The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
Syringe Market Trends, Business Growth and Major Driving Factors 2027
According to our new market research study on “Syringe Market to 2027 – Global Analysis and Forecast – by Syringe Type, Application, Usability and End Use,” the market is expected to reach US$ 26,859.34 million by 2027 from US$ 12,649.46 million in 2019. The market is estimated to grow at a CAGR of 9.8% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.
Grab PDF to Know More (Including Table, Full TOC and Figures) @ https://www.theinsightpartners.com/sample/TIPRE00003521/
Based on syringe type, the market is segmented into luer lock syringes, glass syringes, luer slip syringes, and others. In 2019, the glass syringes segment held the largest share of the market. The segment is expected to grow at the fastest CAGR during the forecast period. This segment is likely to witness a lucrative growth owing to low mechanical tolerance, and smooth movement of the plunger. Furthermore, properties of glass, such as nonreactive nature and heat and chemical resistance, are contributing to the growth of this segment. Moreover, glass syringes are highly compatible with various drug filing devices and are easy to manufacture, which makes them the most preferred syringes in market. In March 2019, Gerresheimer AG launched metal free 1 ml long Luer lock Gx RTF glass syringes to deliver highly complex, protein-based bioengineered molecules.
In the last few years, the health care sector has witnessed SARS, H1N1 and other outbreaks. However, the severity of the coronavirus makes the situation more complex. Additionally, with no vaccine in market and only preventive measure to self-isolation is hitting the various industries including Syringe manufacturing in the region. The US and Canada have witnessed spike in cases in just few days, which has compelled the governments to shut down all the business in order to prevent the spread of the virus.. As of July 2020, in the US, more than 5.0 million confirmed corona cases were recorded and more than 160 thousands deaths were reported due to COVID 19 Pandemic. The syringe market is expected to be hit by the pandemic the most due to increasing number of cases and lockdown in most of the cities.
Becton, Dickinson and Company ; Baxter International Inc.; Terumo Corporation; Vita Needle Company; Cardinal Health Inc.; NIPRO; RETRACTABLE TECHNOLOGIES, INC.; B. Braun Medical Inc.; AIR-TITE PRODUCTS CO., INC.; and HENKE-SASS, WOLF Ltd., are among the leading companies operating in the syringes market.
Chronic diseases, such as diabetes, cardiovascular disease, and cancer, are among the primary causes of death in adults. Infectious diseases are also the top causes of death in children and adults. Chronic and infectious diseases need continuous diagnosis using various medical tests,which requires the use of syringes.
According to the World Health Organization estimations, around 16 billion injections are administered every year globally. It has been estimated that chronic diseases would account for almost three-quarters of all deaths worldwide, and that 75% of deaths due to stroke, 71% of deaths due to ischemic heart disease (IHD), and 70% of deaths due to diabetes would occur in developing countries by 2020. Many of these patients are advised regular intravenous administration of insulin, which increases the demand for syringes.
Infectious diseases are the secondtop cause of deaths worldwide and are among the top causes of death in children under age 5. For instance, the Centers for Disease Control and Prevention (CDC) stated that 1.7 million hospital-acquired infections (HAIs) occurred in 2017, and 99,000 associated deaths occur annually in American hospitals. It is estimated that nearly 32.0% of HAIs are urinary tract infections (UTIs), 22.0% are surgical site infections (SSIs), 15.0% are pneumonia, and 14.0% are bloodstream infections (BSIs).
Table of Contents
· Report Overview: It includes the objectives and scope of the study and gives highlights of key market segments and players covered. It also includes years considered for the research study.
· Executive Summary: It covers industry trends with high focus on market use cases and top market trends, market size by regions, and global market size. It also covers market share and growth rate by regions.
· Key Players: Here, the report concentrates on mergers and acquisitions, expansions, analysis of key players, establishment date of companies, and areas served, manufacturing base, and revenue of key players.
· Breakdown by Product and Application: This section provides details about market size by product and application.
· Regional Analysis: All of the regions and countries analyzed in the report are studied on the basis of market size by product and application, key players, and market forecast.
· Profiles of International Players: Here, players are evaluated on the basis of their gross margin, price, sales, revenue, business, products, and other company details.
· Market Dynamics: It includes supply chain analysis, analysis of regional marketing, challenges,
Continued....
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
Contact Us:
The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com